Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
EX01
- Development stage
- Preclinical
- Lead developer
- Eximium
- Modality
- T-cell Engagers → Multispecific Antibodies → Engineered Antibody Formats → Antibody-Based Therapeutics, CAR-T Cells → Engineered T Cells → Adoptive Cell Transfer → Cell Therapies, Cytotoxic ADCs → Antibody-Drug Conjugates (ADCs) → Antibody Conjugates → Antibody-Based Therapeutics
01
Overview
EX01 is a preclinical oncology drug candidate developed by Eximium. It is part of the company's pipeline utilizing the EximAB™ platform technology, which targets intracellular proteins that are abnormally exposed on the surface of cancer cells. While the specific target for EX01 is not explicitly disclosed in the pipeline, the platform's lead target is SRRM2 (Serine/arginine-rich splicing factor 10). EX01 is described as involving multiple unspecified modalities, which, based on the company's technology, may include monoclonal antibodies, antibody-drug conjugates (ADCs), CAR-T cell therapies, or bispecific T-cell engagers (BiTEs).
Beyond the preview
Go deeper on EX01.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on EX01.